Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don Ganem

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|February 5, 2005
The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAsCraig McCormick, Don Ganem
The Journal of Clinical Investigation|January 1, 2004
Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesisAdam Grundhoff, Don Ganem
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2003
Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signalingYuying Liang, Don Ganem
Cell Host & Microbe|December 17, 2009
Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivationPriya Bellare, Don Ganem
Cell Host & Microbe|July 20, 2010
Viral latency and its regulation: lessons from the gamma-herpesvirusesSamuel H Speck, Don Ganem
The Journal of Clinical Investigation|February 4, 2014
A conversation with Don GanemDon Ganem, Ushma S Neill
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2011
Viral microRNA target allows insight into the role of translation in governing microRNA target accessibilityHorng-Ru Lin, Don Ganem
Journal of Virology|May 28, 2005
A virus-encoded inhibitor that blocks RNA interference in mammalian cellsChristopher S Sullivan, Don Ganem
Cell Host & Microbe|April 23, 2013
A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivityHenry H Chang, Don Ganem
The New England Journal of Medicine|March 12, 2004
Hepatitis B virus infection--natural history and clinical consequencesDon Ganem, Alfred M Prince
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|February 5, 2005
The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAsCraig McCormick, Don Ganem
The Journal of Clinical Investigation|January 1, 2004
Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesisAdam Grundhoff, Don Ganem
Proceedings of the National Academy of Sciences of the United States of America|July 2, 2003
Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signalingYuying Liang, Don Ganem
Cell Host & Microbe|December 17, 2009
Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivationPriya Bellare, Don Ganem
Cell Host & Microbe|July 20, 2010
Viral latency and its regulation: lessons from the gamma-herpesvirusesSamuel H Speck, Don Ganem
The Journal of Clinical Investigation|February 4, 2014
A conversation with Don GanemDon Ganem, Ushma S Neill
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2011
Viral microRNA target allows insight into the role of translation in governing microRNA target accessibilityHorng-Ru Lin, Don Ganem
Journal of Virology|May 28, 2005
A virus-encoded inhibitor that blocks RNA interference in mammalian cellsChristopher S Sullivan, Don Ganem
Cell Host & Microbe|April 23, 2013
A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivityHenry H Chang, Don Ganem
The New England Journal of Medicine|March 12, 2004
Hepatitis B virus infection--natural history and clinical consequencesDon Ganem, Alfred M Prince
Pageof 8